跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10 条关于
“Avicursen”
全部
10
临床试验
0
药物
0
机构
0
资讯
10
2年前
Avicursen Shows Promise in Phase II Trial for Duchenne Muscular Dystrophy
去年
Percheron Therapeutics Completes Avicursen Primate Toxicology Study
去年
Percheron Therapeutics to Broaden Pipeline Following Avicursen Phase IIb Failure in DMD
去年
Percheron Therapeutics' Avicursen Shows Promise in Primate Study, Awaits FDA Discussion
去年
Avicursen Meets Primary Endpoint in Phase 2b Trial for Duchenne Muscular Dystrophy
去年
Percheron Therapeutics Discontinues Avicursen Trial for Duchenne Muscular Dystrophy After Phase 2 Failure
去年
Percheron Therapeutics Halts Trading Awaiting Avicursen Phase IIb Trial Results in Duchenne Muscular Dystrophy
去年
Percheron Therapeutics' Duchenne Muscular Dystrophy Trial Fails to Meet Primary Endpoint
去年
EBR Systems Anticipates FDA Approval for Wireless Pacemaker Lead
去年
Percheron Therapeutics Acquires Phase II-Ready Anti-VISTA Cancer Immunotherapy HMBD-002 in $290M Deal